about
Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorderAcute liver failure induced by carbamazepineCarbamazepine-induced hepatorenal failure in a childCarbamazepine-induced hypersensitivity syndrome in a child with epilepsy.Drug rash with eosinophilia and systemic symptoms syndrome induced by chloral hydrate in early childhood.New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine.Use of antiepileptic drugs for hyperkinetic movement disorders.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.Practical considerations for carbamazepine use in bipolar disorder.Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.Beyond methylphenidate: nonstimulant medications for youth with ADHD.Pharmacogenetic information derived from analysis of HLA alleles.Interaction of carbamazepine with herbs, dietary supplements, and food: a systematic reviewCarbamazepine extended-release capsules in bipolar disorder.HLA-A 31:01 and HLA-B 15:02 as genetic markers for carbamazepine hypersensitivity in children.Vertigo/dizziness as a Drugs' adverse reaction.Supra-therapeutic plasma concentrations of haloperidol induce moderate inhibition of lipopolysaccharide-induced interleukin-8 release in human monocytes.The auditory and vestibular toxicities induced by antiepileptic drugs.Hepatoprotective and antioxidant activity of N-acetyl cysteine in carbamazepine-administered rats.Relationship between Bone Density and Biochemical Markers of Bone among Two Groups Taking Carbamazepine and Sodium Valproate for Epilepsy in Comparison with Healthy Individuals in Yazd.Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity.Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine.A retrospective study of compliance with recommended hematologic monitoring of carbamazepine.Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding.The psychomotor effects of carbamazepine in epileptic patients and healthy volunteers.Chronic application of topiramate and carbamazepine differentially affects the EEG and penicillin-induced epileptiform activity in rats.Alleviation of Trigeminal Nociception Using p75 Neurotrophin Receptor Targeted Lentiviral Interference Therapy.Carbamazepine, a beta-cell protecting drug, reduces type 1 diabetes incidence in NOD mice.A Clinical Study of Toxication Caused by Carbamazepine Abuse in Adolescents.
P2860
Q28260681-8C49801A-2ADF-449C-9EED-39DDDE4A9CFDQ28334840-BF9C3D93-2A2C-4A17-9D16-FCE37E440D43Q28376250-AF20AC0A-441D-41AA-9D8C-501F9E9B6639Q33348017-557BE031-CC87-47A3-8366-F576FD545F05Q33612261-8481FA53-E0BF-42FF-AC16-2E4C717ADBBFQ33949491-B9B265A1-730E-40E9-8C0B-E17AFC233FE8Q34358782-5FB64587-411A-4E41-9DA9-E928D2C739D1Q34829294-6DF4B943-233C-46B2-B349-CB8C46BE7B2AQ36061821-E91E96B6-7787-4DE7-95D3-AB414557CEE3Q36257188-06859338-9C3E-4846-BBFA-4EE734D7ABBCQ36506812-D1976CA8-855A-4642-BF34-5D91EA03674AQ36603317-F085500C-FFE8-4F89-87C8-3D6225D06D89Q36968906-606B5651-B930-4CB8-8FB4-9AA82DDBF582Q37120841-19C8825D-A6EC-44C6-A12E-9E8656362220Q37139662-B3BCEB6A-3E66-4963-953C-E7AA165D01F8Q37165441-575529DC-3A36-4983-A876-F6CFB71EBF2EQ37341208-87E57824-C8CC-4291-A314-2FF5796F5BBEQ37369622-D8EAF945-10EA-43E5-A776-04A56905698BQ37410987-3A5C2073-8A63-4E37-A6C3-3B996E84B329Q38609757-7544002B-D2D4-455D-BAB8-CC35BB96B5BBQ38760681-82529218-6E8B-4EF5-AA7E-44C179D7CF55Q39030320-A6307A69-2A16-4CBF-9808-00AAA8472F75Q40737853-938DDB64-8401-4570-8A59-B83A66D1076DQ40802622-D37121AD-5E6B-409B-9D2F-66C63BB500BEQ43717571-6DA2EC55-12B7-48EA-8526-0BE1D3E1C300Q43936429-89440C5F-DC5B-40FD-9060-3FD1150CBAFDQ44599198-37CC7858-389F-49E7-A083-BFA6F6F0D2A6Q46165220-75546E17-3C01-4E39-A537-690F3B39E135Q50089571-05E7C6C6-7D6D-4040-9CDD-FCA05EF4F771Q51245240-6CAEB833-E791-4E5F-92C4-3D6934A235F2Q55245265-76936F00-4083-44A3-8D47-DFD9E630DE9D
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh
1987年學術文章
@zh-hant
name
Carbamazepine side effects in children and adults.
@en
Carbamazepine side effects in children and adults.
@nl
type
label
Carbamazepine side effects in children and adults.
@en
Carbamazepine side effects in children and adults.
@nl
prefLabel
Carbamazepine side effects in children and adults.
@en
Carbamazepine side effects in children and adults.
@nl
P2860
P1433
P1476
Carbamazepine side effects in children and adults.
@en
P2093
J M Pellock
P2860
P304
P356
10.1111/J.1528-1157.1987.TB05780.X
P478
28 Suppl 3
P577
1987-01-01T00:00:00Z